Key Developments: TearLab Corp (TLB.TO)

TLB.TO on Toronto Stock Exchange

3.40CAD
10:02am EST
Price Change (% chg)

$0.29 (+9.32%)
Prev Close
$3.11
Open
$3.11
Day's High
$3.40
Day's Low
$3.11
Volume
900
Avg. Vol
2,005
52-wk High
$10.95
52-wk Low
$2.50

Search Stocks

Latest Key Developments (Source: Significant Developments)

TearLab Corp lowers FY 2014 revenue guidance
Thursday, 7 Aug 2014 04:08pm EDT 

TearLab Corp:Expects FY 2014 revenue to be in the about range of $22 to $23 mln (prior range of $30 to $33 mln).Based on the company's sales performance in the first half of 2014, and on the timing and anticipated impact of a number of new sales and marketing initiatives introduced earlier in the year.Company believes it can continue to achieve about 20 pct sequential quarter-over-quarter revenue growth in each of the third and fourth quarters.FY 2014 revenue of $26 mln - Thomson Reuters I/B/E/S.  Full Article

TearLab Corp closes acquisition of AOA's OcuHub Technology Platform
Friday, 14 Mar 2014 12:30pm EDT 

TearLab Corp:Closes acquisition of assets of the OcuHub business unit from AOAExcel, Inc., the for-profit subsidiary of the American Optometric Association.As of the close of the transaction, the OcuHub purchased assets and business activities will be operated out of a fully-owned subsidiary of TearLab.Net purchase was about $1.4 mln.  Full Article

TearLab Corporation to acquire AOA's OcuHub Technology Platform
Tuesday, 18 Feb 2014 08:01am EST 

TearLab Corporation:Signs a non-binding term sheet to purchase the assets of the OcuHub business unit from AOAExcel, Inc., the for-profit subsidiary of the American Optometric Association.Says terms of the transaction were not disclosed.Says acquisition is expected to close in March.Says OcuHub, powered by AT&T and Covisint, is an established compliant technology platform designed to securely connect eye doctors, patients, healthcare organizations and payers.  Full Article

TearLab Corp gives Q4, FY 2013 and FY 2014 revenue guidance below analysts' estimates
Monday, 3 Feb 2014 08:00am EST 

TearLab Corp:Expects fourth quarter 2013 to be about $4.5 million, bringing expected fiscal 2013 revenues to about $14.7 million.Anticipates fiscal 2014 revenue to be in the approximate range of $30 million to $33 million.Fourth quarter 2013 revenue of $5.8 million and fiscal 2013 revenue of $15.8 million - Thomson Reuters I/B/E/S.Fiscal 2014 revenue of $36 million - Thomson Reuters I/B/E/S.  Full Article

TearLab Corp Announces Appointment Of President & COO
Tuesday, 1 Oct 2013 08:00am EDT 

TearLab Corp announced that Seph Jensen has been appointed as the Company's President and Chief Operating Officer.  Full Article

Holzer Holzer & Fistel, LLC Announces Investigation Of TearLab Corp
Monday, 5 Aug 2013 12:11pm EDT 

Holzer Holzer & Fistel, LLC announced that it is investigating potential shareholder claims on behalf of investors in Orthofix International NV, AdCare Health Systems Inc and TearLab Corp. The firm is investigating whether the companies complied with federal securities laws in issuing certain public statements.  Full Article

Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of TearLab Corp
Thursday, 1 Aug 2013 06:15pm EDT 

Bronstein, Gewirtz & Grossman, LLC announced that it is investigating potential claims on behalf of purchasers of the securities of TearLab Corporation (TearLab or the Company). The investigation focuses on whether the Company and its executives violated federal securities laws. On August 1, 2013, an article appeared on The Street Sweeper alleging that some of the doctors listed on the Company's website were providers of its diagnostic test for dry eye disease (DED) no longer use the machine and had already returned it. On this news, shares of TearLab fell $1.30 or 9.19% to close at $12.85.  Full Article

TearLab Corp Announces Exercise Of Underwriters' Over-allotment Option And Closing Of $40.4 Million Public Offering Of Common Stock
Tuesday, 30 Jul 2013 11:40am EDT 

TearLab Corp announced that it has closed the previously announced underwritten public offering of 2,990,000 shares of its common stock at a price to the public of $13.50 per share for gross proceeds of approximately $40.4 million. The shares include 390,000 shares of common stock sold pursuant to the over-allotment option granted by TearLab to the underwriters, which option was exercised in full. The net proceeds from the sale of the shares, after deducting the underwriters' discounts and other estimated offering expenses payable by TearLab, will be approximately $37.5 million. TearLab plans to use the net proceeds from this offering for commercialization of its products, research and development, working capital and other general corporate purposes. Canaccord Genuity Inc. and Craig-Hallum Capital Group LLC acted as joint book-running managers for the offering. Roth Capital Partners, LLC and Feltl and Company, Inc. acted as co-managers.  Full Article

TearLab Corp Prices $35.1 Million Public Offering Of Common Stock
Thursday, 25 Jul 2013 09:01am EDT 

TearLab Corp announced the pricing of an underwritten public offering of 2,600,000 shares of its common stock at a price to the public of $13.50 per share for gross proceeds of $35.1 million. The net proceeds from the sale of the shares, after deducting the underwriters' discounts and other estimated offering expenses payable by TearLab, will be approximately $32.6 million. TearLab has also granted the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering to cover overallotments. TearLab currently plans to use the net proceeds from this offering for commercialization of its products, research and development, working capital and other general corporate purposes. The offering is expected to close on or about July 30, 2013, subject to the satisfaction of customary closing conditions. Canaccord Genuity Inc. and Craig-Hallum Capital Group LLC are acting as joint book-running managers for the offering. Roth Capital Partners, LLC and Feltl and Company, Inc. are acting as co-managers.  Full Article

TearLab Corp Issues Q2 2013 Revenue Guidance In Line With Analysts' Estimates
Monday, 22 Jul 2013 07:00am EDT 

TearLab Corp announced that it estimates that total revenue for the second quarter of 2013 will be in the range of $3.4 million to $3.6 million. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $3.5 million for the second quarter of 2013.  Full Article

Search Stocks